TEVA/ PLANTEX TAPI unit of API Division TEVA Pharmaceutical Industries JA – 756
This Rx-360 Audit Report contains the following scope:
The scope of the audit was focused on the main processes as manufacturing, packaging,
labeling, testing and distribution of Allopurinol.
The audit was based on Rx-360 Audit standards for Active Pharmaceutical Ingredients (APIs)
and API Intermediates and also included a supply chain security component based on the Rx360
Consortium Supply Chain Security Checklist.